Fatty acid metabolic pathways in CRC patients may be potential specific targets for CRC therapy
The first identified incretin was a gastric inhibitory peptide (GIP) with the activity of inhibiting the secretion of gastric acid, which was isolated from porcine small intestines ( + channel and depolarize the cell membrane, while also activate the voltage-dependent Ca 2+ channel, causing a Ca 2+ inflow and the generation of action potentials ( 2+ release by activating inositol triphosphate (IP3)
No syringe, no pen, no needle
It is also approved for the treatment of moderate-to-severe obstructive sleep apnea in adults with obesity
GLP-1 RAs promote satiety, reduce hunger, and dampen reward responsivity, which conceptually could open a temporary low-drive window during which behavioral techniques such as stimulus control, self-monitoring, and structured eating routines become more achievable